Ainos, Inc.(AIMD)Earnings, Financials & Key Ratios
AIMD•NASDAQ
$1.77
$8M mkt cap·Price updated May 6, 2026
AboutAinos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.Show more
- Revenue$21K-83.0%
- EBITDA-$9M-8.4%
- Net Income-$15M-7.9%
- EPS (Diluted)-1.56+53.6%
- Gross Margin-153.73%+26.0%
- EBITDA Margin-43607.93%-538.9%
- Operating Margin-66772.17%-517.4%
- Net Margin-71702.26%-535.8%
- ROE-74.38%-59.6%
- ROIC-39.81%-25.7%
- Debt/Equity0.77+217.0%
- Interest Coverage-22.45+75.5%
AIMD Key Insights
Ainos, Inc. (AIMD) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y sales CAGR of 12.1%
- ✓Trading at only 1.1x book value
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 19 (bottom 19%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Shares diluted 100.0% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
AIMD Price & Volume
Ainos, Inc. (AIMD) stock price & volume — 10-year historical chart
Loading chart...
AIMD Growth Metrics
Ainos, Inc. (AIMD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years12.06%
3 Years-67.33%
TTM178.19%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM7.29%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-7482.25%
Return on Capital
10 Years-161.7%
5 Years-58.81%
3 Years-50.95%
Last Year-50%
AIMD Peer Comparison
Ainos, Inc. (AIMD) competitors in Diagnostics and Omics Tools — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 AEYE | 95.09M | 7.66 | -30.64 | 14.52% | -7.63% | -47.8% | 0.15 | |
 XTLB | 357.58K | 3.25 | -0.34 | -227.72% | -25.53% | 0.03 | ||
 SABS | 180.92M | 3.80 | -4.81 | -100% | 15.17% | 0.04 | ||
 NNOX | 117.04M | 1.79 | -1.97 | 13.91% | -452.82% | -35.55% | 0.04 | |
 INVA | 1.91B | 22.52 | 6.82 | 18.52% | 118.91% | 46.47% | 0.23 | |
 SENS | 221.18M | 5.36 | -3.23 | 56.89% | -196.03% | -113.21% | 0.67 | |
 ILMN | 21.66B | 142.58 | 26.16 | -0.78% | 19.43% | 32.84% | 0.94 | |
 TMO | 175.76B | 472.95 | 26.66 | 3.91% | 15.18% | 13.23% | 0.76 |
Compare AIMD vs Peers
Ainos, Inc. (AIMD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
AIMD Income Statement
Ainos, Inc. (AIMD) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 250.93K | 77.72K | 11.73K | 16.56K | 594.56K | 3.52M | 122.11K | 20.73K | 113.04K |
| Revenue Growth % | -100% | - | -69.03% | -84.91% | 41.19% | 3489.71% | 491.97% | -96.53% | -83.02% | 178.19% |
| Cost of Goods Sold | 25.96K | 60.32K | 64.88K | 8.77K | 11.28K | 184.18K | 2.11M | 375.85K | 52.59K | 19.57K |
| COGS % of Revenue | - | 24.04% | 83.47% | 74.78% | 68.09% | 30.98% | 60.07% | 307.79% | 253.73% | - |
| Gross Profit | -25.96K▲ 0% | 190.61K▲ 834.4% | 12.85K▼ 93.3% | 2.96K▼ 77.0% | 5.29K▲ 78.6% | 410.38K▲ 7663.6% | 1.41M▲ 242.4% | -253.73K▼ 118.1% | -31.87K▲ 87.4% | 93.47K▲ 0% |
| Gross Margin % | - | 75.96% | 16.53% | 25.22% | 31.91% | 69.02% | 39.93% | -207.79% | -153.73% | 82.69% |
| Gross Profit Growth % | -45.84% | 834.37% | -93.26% | -76.97% | 78.64% | 7663.56% | 242.45% | -118.05% | 87.44% | - |
| Operating Expenses | 667.11K | 770.38K | 1.35M | 1.58M | 1.45M | 4.28M | 15.38M | 12.95M | 13.81M | 14.42M |
| OpEx % of Revenue | - | 307.01% | 1733.73% | 13497.33% | 8728.62% | 719.49% | 437.02% | 10607.2% | 66618.45% | - |
| Selling, General & Admin | 667.11K | 770.38K | 1.31M | 1.53M | 1.45M | 2.36M | 8.54M | 5.64M | 5.4M | 6.46M |
| SG&A % of Revenue | - | 307.01% | 1691.8% | 13049.71% | 8726.27% | 396.45% | 242.51% | 4614.84% | 26028.34% | - |
| Research & Development | 0 | 0 | 32.59K | 52.51K | 389 | 1.92M | 6.85M | 7.32M | 8.41M | 7.95M |
| R&D % of Revenue | - | - | 41.93% | 447.62% | 2.35% | 323.03% | 194.51% | 5992.36% | 40590.11% | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -667.11K▲ 0% | -579.76K▲ 13.1% | -1.33M▼ 130.2% | -1.58M▼ 18.4% | -1.44M▲ 8.9% | -3.87M▼ 168.5% | -13.98M▼ 261.4% | -13.21M▲ 5.5% | -13.84M▼ 4.8% | -14.33M▲ 0% |
| Operating Margin % | - | -231.05% | -1717.2% | -13472.11% | -8696.7% | -650.47% | -397.09% | -10814.99% | -66772.17% | -12674% |
| Operating Income Growth % | -28.33% | 13.09% | -130.21% | -18.41% | 8.86% | -168.49% | -261.38% | 5.51% | -4.81% | - |
| EBITDA | -641.15K | -539.77K | -1.28M | -1.56M | -1.43M | -1.82M | -9.16M | -8.34M | -9.04M | -9.56M |
| EBITDA Margin % | - | -215.11% | -1644.9% | -13282.52% | -8607.96% | -306.61% | -260.33% | -6825.98% | -43607.93% | -8454.66% |
| EBITDA Growth % | -28.22% | 15.81% | -136.86% | -21.88% | 8.5% | -27.86% | -402.61% | 9.03% | -8.45% | 5.2% |
| D&A (Non-Cash Add-back) | 25.96K | 39.99K | 56.19K | 22.24K | 14.7K | 2.04M | 4.81M | 4.87M | 4.8M | 4.77M |
| EBIT | -667.11K | -579.76K | -1.33M | -1.58M | -1.44M | -3.87M | -13.95M | -13.63M | -14.25M | -14.24M |
| Net Interest Income | 0 | -37.61K | -3.96K | -885 | -10.19K | -18.69K | -53.53K | -144.19K | -616.47K | -719.36K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.87K | 37.61K | 3.96K | 885 | 10.19K | 18.69K | 53.53K | 144.19K | 616.47K | 719.36K |
| Other Income/Expense | -2.87K | -37.61K | -3.96K | -885 | -10.19K | -5.09K | -30.48K | -563.35K | -1.02M | -629.62K |
| Pretax Income | -669.98K▲ 0% | -617.38K▲ 7.9% | -1.34M▼ 116.8% | -1.58M▼ 18.1% | -1.45M▲ 8.3% | -3.87M▼ 167.0% | -14.01M▼ 261.7% | -13.77M▲ 1.7% | -14.86M▼ 7.9% | -14.96M▲ 0% |
| Pretax Margin % | - | -246.04% | -1722.3% | -13479.65% | -8758.21% | -651.32% | -397.96% | -11276.33% | -71698.4% | -13231% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 16.14K | 0 | 800 | 800 | 800 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | -0.42% | 0% | -0.01% | -0.01% | -0.01% |
| Net Income | -669.98K▲ 0% | -617.38K▲ 7.9% | -1.34M▼ 116.8% | -1.58M▼ 18.2% | -1.45M▲ 8.3% | -3.89M▼ 168.1% | -14.01M▼ 260.2% | -13.77M▲ 1.7% | -14.86M▼ 7.9% | -14.96M▲ 0% |
| Net Margin % | - | -246.04% | -1722.3% | -13487.2% | -8758.21% | -654.04% | -397.96% | -11276.98% | -71702.26% | -13231.71% |
| Net Income Growth % | -28.38% | 7.85% | -116.83% | -18.19% | 8.32% | -168.07% | -260.19% | 1.69% | -7.93% | 7.29% |
| Net Income (Continuing) | -669.98K | -617.38K | -1.34M | -1.58M | -1.45M | -3.89M | -14.01M | -13.77M | -14.86M | -14.96M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.50▲ 0% | -0.41▲ 18.0% | -0.56▼ 36.6% | -0.74▼ 32.1% | -2.69▼ 263.5% | -2.59▲ 3.7% | -5.14▼ 98.5% | -3.36▲ 34.6% | -1.56▲ 53.6% | -3.28▲ 0% |
| EPS Growth % | -28.21% | 18% | -36.59% | -32.14% | -263.51% | 3.72% | -98.46% | 34.63% | 53.57% | -7482.25% |
| EPS (Basic) | -0.50 | -0.41 | -0.56 | -0.74 | -2.69 | -2.59 | -5.14 | -3.36 | -1.56 | - |
| Diluted Shares Outstanding | 1.34M | 1.51M | 2.38M | 2.15M | 543.08K | 1.51M | 2.73M | 4.1M | 9.5M | 4.55M |
| Basic Shares Outstanding | 1.34M | 1.51M | 2.38M | 2.15M | 543.08K | 1.51M | 2.73M | 4.1M | 9.5M | 4.55M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
AIMD Balance Sheet
Ainos, Inc. (AIMD) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 262.4K | 2.08M | 1.3M | 445.29K | 76.41K | 2.22M | 2.85M | 2.47M | 4.34M | 1.72M |
| Cash & Short-Term Investments | 134.13K | 1.98M | 1.28M | 409.04K | 22.25K | 1.75M | 1.85M | 1.89M | 3.89M | 1.13M |
| Cash Only | 134.13K | 1.98M | 1.28M | 409.04K | 22.25K | 1.75M | 1.85M | 1.89M | 3.89M | 1.13M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | -32.12K | 0 | 0 | 201.55K | 455 | 56 | 62 |
| Days Sales Outstanding | - | - | - | - | - | - | 20.9 | 1.36 | 0.99 | 0.32 |
| Inventory | 14.7K | 22.67K | 0 | 4.13K | 3.02K | 0 | 595.22K | 167.59K | 143.76K | 166.88K |
| Days Inventory Outstanding | 206.72 | 137.16 | - | 171.89 | 97.88 | - | 102.76 | 162.76 | 997.64 | 2.86K |
| Other Current Assets | 0 | 0 | 26.58K | 32.12K | 0 | 466.2K | 195.79K | 419.52K | 301.08K | 425.75K |
| Total Non-Current Assets | 200.28K | 209.38K | 160.47K | 151.33K | 183.88K | 38.6M | 34.26M | 29.37M | 24.48M | 20.96M |
| Property, Plant & Equipment | 44.21K | 27K | 14.01K | 5.07K | 3.25K | 1.19M | 1.38M | 876.57K | 559.64K | 414.56K |
| Fixed Asset Turnover | - | 9.29x | 5.55x | 2.31x | 5.10x | 0.50x | 2.56x | 0.14x | 0.04x | 0.23x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 156.06K | 182.39K | 146.46K | 146.26K | 180.63K | 37.33M | 32.81M | 28.28M | 23.75M | 20.37M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | -151.33K | 0 | 87.57K | 80.68K | 208.83K | 174.42K | 714.19K |
| Total Assets | 462.68K▲ 0% | 2.29M▲ 395.8% | 1.46M▼ 36.2% | 596.63K▼ 59.2% | 260.29K▼ 56.4% | 40.82M▲ 15583.3% | 37.11M▼ 9.1% | 31.84M▼ 14.2% | 28.82M▼ 9.5% | 22.68M▲ 0% |
| Asset Turnover | - | 0.11x | 0.05x | 0.02x | 0.06x | 0.01x | 0.09x | 0.00x | 0.00x | 0.00x |
| Asset Growth % | 294.79% | 395.78% | -36.19% | -59.24% | -56.37% | 15583.34% | -9.1% | -14.19% | -9.49% | -81.31% |
| Total Current Liabilities | 1.27M | 1.82M | 733.62K | 753.31K | 1.1M | 30.59M | 2.47M | 1.34M | 3.95M | 581.36K |
| Accounts Payable | 168.76K | 159.3K | 115.31K | 208.73K | 145.57K | 0 | 0 | 0 | 0 | 0 |
| Days Payables Outstanding | 2.37K | 964 | 648.75 | 8.69K | 4.71K | - | - | - | - | - |
| Short-Term Debt | 791.48K | 886.48K | 513.36K | 444.58K | 953K | 3.59M | 1.26M | 42K | 3M | 0 |
| Deferred Revenue (Current) | 124.83K | 0 | 0 | 0 | 0 | 0 | 0 | 112.56K | 106.33K | 106.33K |
| Other Current Liabilities | 190.76K | 777.26K | 104.95K | 100K | -145.57K | 0 | 0 | 0 | 0 | 581.36K |
| Current Ratio | 0.21x | 1.14x | 1.78x | 0.59x | 0.07x | 0.07x | 1.15x | 1.85x | 1.10x | 1.10x |
| Quick Ratio | 0.19x | 1.13x | 1.78x | 0.59x | 0.07x | 0.07x | 0.91x | 1.72x | 1.06x | 1.06x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | 2.86K |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 30.25K | 8.1K | 6.06M | 9.35M | 12.05M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.92M | 9M | 11M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 30.25K | 8.1K | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 135.83K | 348.94K | 2.99M |
| Total Liabilities | 1.27M | 1.82M | 733.62K | 753.31K | 1.1M | 30.63M | 2.48M | 7.39M | 13.3M | 12.63M |
| Total Debt | 791.48K | 886.48K | 513.36K | 444.58K | 953K | 3.62M | 1.27M | 5.96M | 12M | 11M |
| Net Debt | 657.36K | -1.09M | -763.3K | 35.54K | 930.76K | 1.87M | -584.74K | 4.08M | 8.11M | 9.87M |
| Debt / Equity | - | 1.88x | 0.70x | - | - | 0.36x | 0.04x | 0.24x | 0.77x | 0.77x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | -1.15x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | -1.03x |
| Interest Coverage | -232.36x | -15.41x | -336.78x | -1785.78x | -141.39x | -206.94x | -261.10x | -91.59x | -22.45x | -19.79x |
| Total Equity | -809.9K▲ 0% | 470.8K▲ 158.1% | 730.08K▲ 55.1% | -156.68K▼ 121.5% | -838.28K▼ 435.0% | 10.2M▲ 1316.4% | 34.63M▲ 239.6% | 24.45M▼ 29.4% | 15.52M▼ 36.5% | 10.04M▲ 0% |
| Equity Growth % | -71.57% | 158.13% | 55.07% | -121.46% | -435.02% | 1316.44% | 239.59% | -29.4% | -36.53% | -167.69% |
| Book Value per Share | -0.60 | 0.31 | 0.31 | -0.07 | -1.54 | 6.75 | 12.70 | 5.97 | 1.63 | 2.21 |
| Total Shareholders' Equity | -809.9K | 470.8K | 730.08K | -156.68K | -838.28K | 10.2M | 34.63M | 24.45M | 15.52M | 10.04M |
| Common Stock | 219.16K | 231.56K | 391.18K | 405.16K | 420.66K | 96.25K | 40.02K | 46.78K | 154.27K | 47.94K |
| Retained Earnings | -1.27M | -1.88M | -3.19M | -4.77M | -6.22M | -10.11M | -24.12M | -37.89M | -52.75M | -63.05M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 5.8K | -201.65K | -268.85K | -409.53K | -214.48K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
AIMD Cash Flow Statement
Ainos, Inc. (AIMD) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -520.81K | -542.7K | -1.01M | -909.48K | -499.55K | -1.25M | -3.04M | -4.69M | -5.81M | -5.81M |
| Operating CF Margin % | - | -216.28% | -1298.44% | -7752.76% | -3016.07% | -210.23% | -86.39% | -3844.56% | -28020.01% | - |
| Operating CF Growth % | -42.14% | -4.2% | -85.96% | 9.88% | 45.07% | -150.22% | -143.26% | -54.39% | -23.72% | 106.41% |
| Net Income | -669.98K | -617.38K | -1.34M | -1.58M | -1.45M | -3.89M | -14.01M | -13.77M | -14.86M | -14.96M |
| Depreciation & Amortization | 25.96K | 39.99K | 56.19K | 22.24K | 14.7K | 2.04M | 4.83M | 4.85M | 4.8M | 4.77M |
| Stock-Based Compensation | 0 | 106.25K | 100.37K | 0 | 524.78K | 150.29K | 6.42M | 1.11M | 3.54M | 3.95M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 66.61K | 38.89K | 27.77K | 395.04K | 0 | 2.22K | 0 | 2.9M | 672.96K | 1.1M |
| Working Capital Changes | 123.22K | -110.46K | 145.12K | 254.54K | 411.6K | 441.72K | -289.35K | 189.8K | 37.12K | 509.89K |
| Change in Receivables | -93.87K | 31.8K | -502.01K | 0 | 0 | 0 | -201.55K | 201.09K | 399 | -62 |
| Change in Inventory | -14.7K | -7.97K | 22.67K | -4.13K | 1.11K | 3.02K | -595.22K | 221.77K | 23.84K | -6.18K |
| Change in Payables | 106.95K | -9.46K | 54.84K | 261.67K | 419.62K | 794.17K | 0 | 0 | 0 | 0 |
| Cash from Investing | -148.33K | -49.1K | -7.28K | -13.11K | -7.24K | -180.52K | -630.18K | -101.53K | -125.29K | 173 |
| Capital Expenditures | -148.33K | -49.1K | -7.28K | -13.11K | -7.24K | -143.79K | -633.82K | -92.98K | -21.33K | -37K |
| CapEx % of Revenue | - | 19.57% | 9.36% | 111.73% | 43.73% | 24.18% | 18.01% | 76.15% | 102.9% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -100.64K | -49.1K | -2.37K | 0 | 0 | -36.73K | 3.65K | -8.54K | -103.96K | 37.17K |
| Cash from Financing | 782.13K | 2.44M | 254.98K | 54.97K | 120K | 3.15M | 3.85M | 4.92M | 8.03M | 582.63K |
| Debt Issued (Net) | 262.5K | 95K | 0 | -70.08K | 120K | 3.09M | 2.07M | 5.31M | 8.12M | -1.27M |
| Equity Issued (Net) | 0 | 144.36K | 0 | 125.05K | 0 | 0 | 1000K | -301 | 0 | 1.72M |
| Dividends Paid | 0 | 0 | -34.28K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -301 | 0 | 0 |
| Other Financing | 519.63K | 2.2M | 289.26K | 0 | 0 | 64.75K | 0 | -390K | -97.5K | 0 |
| Net Change in Cash | 112.99K▲ 0% | 1.85M▲ 1533.7% | -761.5K▼ 141.3% | -867.62K▼ 13.9% | -386.79K▲ 55.4% | 1.73M▲ 547.1% | 101.86K▼ 94.1% | 32.27K▼ 68.3% | 2.01M▲ 6121.1% | -4.03M▲ 0% |
| Free Cash Flow | -669.14K▲ 0% | -591.8K▲ 11.6% | -1.02M▼ 71.8% | -922.58K▲ 9.2% | -506.79K▲ 45.1% | -1.39M▼ 175.0% | -3.67M▼ 163.6% | -4.79M▼ 30.3% | -5.83M▼ 21.8% | -4.66M▲ 0% |
| FCF Margin % | - | -235.84% | -1307.8% | -7864.49% | -3059.8% | -234.42% | -104.4% | -3920.71% | -28122.91% | -4123.35% |
| FCF Growth % | -77.02% | 11.56% | -71.76% | 9.24% | 45.07% | -175.02% | -163.64% | -30.29% | -21.76% | 26.28% |
| FCF per Share | -0.50 | -0.39 | -0.43 | -0.43 | -0.93 | -0.92 | -1.35 | -1.17 | -0.61 | -0.61 |
| FCF Conversion (FCF/Net Income) | 0.78x | 0.88x | 0.75x | 0.57x | 0.34x | 0.32x | 0.22x | 0.34x | 0.39x | 0.31x |
| Interest Paid | 0 | 0 | 0 | 903 | 0 | 19.38K | 43.25K | 16.9K | 21.67K | 17.74K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 800 | 800 | 0 |
AIMD Key Ratios
Ainos, Inc. (AIMD) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | -131.13% | -222.94% | -551.86% | - | -83.1% | -62.49% | -46.62% | -74.38% | -119.35% |
| Return on Invested Capital (ROIC) | - | - | - | - | - | -47.71% | -45.47% | -31.66% | -39.81% | -39.81% |
| Gross Margin | - | 75.96% | 16.53% | 25.22% | 31.91% | 69.02% | 39.93% | -207.79% | -153.73% | 82.69% |
| Net Margin | - | -246.04% | -1722.3% | -13487.2% | -8758.21% | -654.04% | -397.96% | -11276.98% | -71702.26% | -13231.71% |
| Debt / Equity | - | 1.88x | 0.70x | - | - | 0.36x | 0.04x | 0.24x | 0.77x | 0.77x |
| Interest Coverage | -232.36x | -15.41x | -336.78x | -1785.78x | -141.39x | -206.94x | -261.10x | -91.59x | -22.45x | -19.79x |
| FCF Conversion | 0.78x | 0.88x | 0.75x | 0.57x | 0.34x | 0.32x | 0.22x | 0.34x | 0.39x | 0.31x |
| Revenue Growth | -100% | - | -69.03% | -84.91% | 41.19% | 3489.71% | 491.97% | -96.53% | -83.02% | 178.19% |
AIMD Frequently Asked Questions
Ainos, Inc. (AIMD) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Ainos, Inc. (AIMD) reported $0.1M in revenue for fiscal year 2024. This represents a 92% decrease from $1.4M in 1995.
Ainos, Inc. (AIMD) saw revenue decline by 83.0% over the past year.
Ainos, Inc. (AIMD) reported a net loss of $15.0M for fiscal year 2024.
Dividend & Returns
Ainos, Inc. (AIMD) has a return on equity (ROE) of -74.4%. Negative ROE indicates the company is unprofitable.
Ainos, Inc. (AIMD) had negative free cash flow of $4.7M in fiscal year 2024, likely due to heavy capital investments.
Explore More AIMD
Ainos, Inc. (AIMD) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates